Registry and Prevalence of Gene Mutation in Korean Patients With Familial Hypertrophic Cardiomyopathy

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Yonsei University
ClinicalTrials.gov Identifier:
NCT01792960
First received: February 7, 2013
Last updated: February 17, 2014
Last verified: February 2014

February 7, 2013
February 17, 2014
February 2013
August 2013   (final data collection date for primary outcome measure)
1) DNA analysis [ Time Frame: 1 year ] [ Designated as safety issue: No ]
1) Identify susceptible genes for familial hypertrophic cardiomyopathy in Korean
Same as current
Complete list of historical versions of study NCT01792960 on ClinicalTrials.gov Archive Site
2) Prognosis of familial hypertrophic cariomyopathy [ Time Frame: 1 year ] [ Designated as safety issue: No ]
2) all-cause mortality, hospitalization for heart failure progression, stroke, heart transplantation
Same as current
Not Provided
Not Provided
 
Registry and Prevalence of Gene Mutation in Korean Patients With Familial Hypertrophic Cardiomyopathy
Not Provided

Set the Korean Familial Hypertrophic Cardiomyopathy (KFHC) registry to study the prevalence of gene mutations in Korean patients with familial hypertrophic cardiomyopathy

Not Provided
Observational [Patient Registry]
Observational Model: Cohort
Time Perspective: Prospective
2 Years
Retention:   Samples With DNA
Description:

serum, whole blood, DNA

Non-Probability Sample

familial hypertrophic cardiomyopathy patients and their relatives

Familial Hypertrophic Cardiomyopathy
Not Provided
familial hypertrophic cardiomyopathy
familial hypertrophic cardiomyopathy patients and their relatives
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
99
August 2013
August 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  1. left ventricular maximal wall thickness ≥ 15mm on echocardiography
  2. hypertrophic cardiomyopathy patients' relatives

Exclusion Criteria:

  1. other cardiomyopathy or systemic disease (e.g. fabry disease, danon disease, glycogen storage disease)
  2. who deny the study entrance, especially in patients' relatives
Both
13 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Korea, Republic of
 
NCT01792960
4-2012-0869
Yes
Yonsei University
Yonsei University
Not Provided
Not Provided
Yonsei University
February 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP